why choose us

First received: May 25, 2023

Clinical Trial: SAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects

Study Status: Completed

Recruit Status: RECRUITING

Condition: Retinal Dystrophy

Study Type: INTERVENTIONAL


Official Title: A Phase 1 Open-Label, Single Arm Dose Escalation Study to Evaluate the Safety and Tolerability of Intravitreally Administered VP-001 in Participants With Confirmed PRPF31 Mutation-Associated Retinal D

Brief Summary: A Phase 1 Open-Label, Single Arm Dose Escalation Study to Evaluate the Safety and Tolerability of Intravitreally Administered VP-001 in Participants with Confirmed PRPF31 Mutation-Associated Retinal Dystrophy

Read more